Novo Nordisk’s Ozempic and Wegovy continue to outpace Eli Lilly’s Mounjaro and Zepbound, even though the latter are demonstrably more effective in clinical trials. The most recent earnings reports ...

We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we ...

Politically conservative “pro-family” groups ended 2024 by calling to stamp out the “transgender cult,” opposing ...

Of course, product launches were another hot topic in the top 10. Kenvue landed two stories there: Tylenol’s “Easy to Swallow” brand extension at no. 5, and Versalie, which provides virtual menopause ...

The drugmaker launched a campaign supporting its weight loss medication Contrave, all backed by a cover version of Lesley Gore’s 1963 hit “You Don’t Own Me.” ...

To accomplish these goals, it's fair to assume that some people will ultimately turn to weight-loss drugs such as Ozempic and ...

Even the most iconic brand occasionally finds itself at a crossroads. A strong identity can keep you relevant for decades, ...

From childhood malaria vaccines to record-breaking solar panels to the discovery of a lost ancient city, this tumultuous year ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

The best ad blockers are the perfect solution for boosting your browser speed, block pop-ups and reduce advertising from collecting data through invasive cookies. Some services will even help ...